Marker Therapeutics, Inc. (MRKR)
2.10
+0.06
(+2.94%)
USD |
NASDAQ |
Jan 23, 16:00
2.09
-0.01
(-0.48%)
After-Hours: 20:00
Marker Therapeutics EPS Diluted (TTM): -1.229 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| ADMA Biologics, Inc. | 0.8515 |
| Viridian Therapeutics, Inc. | -3.534 |
| Kiniksa Pharmaceuticals International Plc | 0.4483 |
| Neurocrine Biosciences, Inc. | 4.187 |
| AIM ImmunoTech, Inc. | -14.93 |